In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system.?
This report contains market size and forecasts of Allergic Rhinitis Drugs in globa
- Global Allergic Rhinitis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Allergic Rhinitis Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
l, including the following market information:Global top five Allergic Rhinitis Drugs companies in 2021 (%)
The global Allergic Rhinitis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Allergic Rhinitis Drugs include GlaxoSmithKline, Sanofi, ALK-Abell?, Meda Pharmaceuticals, Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Allergic Rhinitis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allergic Rhinitis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Allergic Rhinitis Drugs Market Segment Percentages, by Type, 2021 (%)
- Antihistamines
- Intranasal Corticosteroids
- Immunotherapies
Global Allergic Rhinitis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Allergic Rhinitis Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Allergic Rhinitis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Allergic Rhinitis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Allergic Rhinitis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Allergic Rhinitis Drugs revenues share in global market, 2021 (%)
- Key companies Allergic Rhinitis Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Allergic Rhinitis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Sanofi
- ALK-Abell?
- Meda Pharmaceuticals
- Adamis Pharmaceuticals
- Allergy Therapeutics
- Almirall
- Ampio
- AstraZeneca
- Amneal Pharmaceuticals
- Anergis
- Apotex
- Array BioPharma
- Aspen Pharmacare
- Circassia Pharmaceuticals
- Dr Reddy's Laboratories
- Eddingpharm
- EMS
- HAL Allergy
- Inmunotek
- Genentech
- Greer Laboratories
- Glenmark Pharmaceuticals
- Hanmi Pharmaceuticals
- Hisamitsu Pharmaceutical
- Intas Pharmaceuticals
- Novartis
